Ababax is an early stage company working towards the translation of scientific findings into therapeutic approaches based on digital, non-invasive sensory stimulation.

Longevity Biomedical develops and acquires technologies spanning therapeutics, health monitoring, and digital health solutions. It provides longevity-related products and services designed to improve the health span of the aging population. It cultures and researches soft tissue repair, corneal transplant, ischemic stroke, and more pipelines. The company was founded in 2022 and is based in Bothell, Washington.

The utmost focus of anything we do is to positively impact the patients’ health journey. Four departments closely collaborate within our team: The discovery team explores how scientific breakthroughs and revolutionary technologies can combine to add value for patients worldwide. Our applied scientists conduct clinical trials and prove the efficacy of new Digital Drugs. Based on this scientific evidence and under strict regulations, our dev team develops innovative Software-as-a-Drug solutions. Finally, operational management ensures an efficient workflow.

Our company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span.